Special Plenary to Focus on IASLC’s Role in Shaping Thoracic Cancer Research, Treatment

HARMONi-2 Study Findings May Reshape the Therapeutic Paradigm of Frontline Driver Mutation-Negative Advanced NSCLC

NeoCOAST-2 Shows Pathologic Response Benefit for Perioperative Durvalumab + ADC + Chemotherapy Combination

Plenary Session Will Unveil Impact of Non-Tobacco Factors in Lung Cancer Risk

Lung Cancer Beyond Smoking: Outdoor Air Pollution and Lung Cancer

Surgical Challenges and Opportunities in Locally Advanced NSCLC

Analysis of Membrane-Bound TROP2 in TROPION-Lung01 Underscores Seminal Advance in Lung Cancer Digital Pathology

FURTHER Study Moves the Needle Farther on Targeted Therapy Directed at Atypical EGFR Mutations in NSCLC

Aumolertinib After CRT Significantly Improves PFS in EGFR-mutated Unresectable NSCLC

Closing Plenary Will Focus on the Importance of Advancing Patient Advocacy

IASLC Looks Back at 50 Years of Growth, Collaboration, and Progress in Lung Cancer